Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 6
1990 1
1992 3
1993 1
1994 1
1995 1
1996 2
1997 1
1998 8
1999 11
2000 4
2001 5
2002 9
2003 9
2004 6
2005 8
2006 3
2007 6
2008 9
2009 10
2010 19
2011 12
2012 17
2013 13
2014 15
2015 16
2016 18
2017 20
2018 22
2019 32
2020 15
2021 4
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

290 results
Results by year
Filters applied: . Clear all
Page 1
Novel therapies for epilepsy in the pipeline.
Mesraoua B, Deleu D, Kullmann DM, Shetty AK, Boon P, Perucca E, Mikati MA, Asadi-Pooya AA. Mesraoua B, et al. Among authors: kullmann dm. Epilepsy Behav. 2019 Aug;97:282-290. doi: 10.1016/j.yebeh.2019.04.042. Epub 2019 Jul 6. Epilepsy Behav. 2019. PMID: 31284159 Review.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2018 Oct 1;141(10):2823. doi: 10.1093/brain/awy249. Brain. 2018. PMID: 31367749 No abstract available.
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.
Salpietro V, Dixon CL, Guo H, Bello OD, Vandrovcova J, Efthymiou S, Maroofian R, Heimer G, Burglen L, Valence S, Torti E, Hacke M, Rankin J, Tariq H, Colin E, Procaccio V, Striano P, Mankad K, Lieb A, Chen S, Pisani L, Bettencourt C, Männikkö R, Manole A, Brusco A, Grosso E, Ferrero GB, Armstrong-Moron J, Gueden S, Bar-Yosef O, Tzadok M, Monaghan KG, Santiago-Sim T, Person RE, Cho MT, Willaert R, Yoo Y, Chae JH, Quan Y, Wu H, Wang T, Bernier RA, Xia K, Blesson A, Jain M, Motazacker MM, Jaeger B, Schneider AL, Boysen K, Muir AM, Myers CT, Gavrilova RH, Gunderson L, Schultz-Rogers L, Klee EW, Dyment D, Osmond M, Parellada M, Llorente C, Gonzalez-Peñas J, Carracedo A, Van Haeringen A, Ruivenkamp C, Nava C, Heron D, Nardello R, Iacomino M, Minetti C, Skabar A, Fabretto A; SYNAPS Study Group; Raspall-Chaure M, Chez M, Tsai A, Fassi E, Shinawi M, Constantino JN, De Zorzi R, Fortuna S, Kok F, Keren B, Bonneau D, Choi M, Benzeev B, Zara F, Mefford HC, Scheffer IE, Clayton-Smith J, Macaya A, Rothman JE, Eichler EE, Kullmann DM, Houlden H. Salpietro V, et al. Among authors: kullmann dm. Nat Commun. 2019 Jul 12;10(1):3094. doi: 10.1038/s41467-019-10910-w. Nat Commun. 2019. PMID: 31300657 Free PMC article.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2020 Oct 1;143(10):2863. doi: 10.1093/brain/awaa319. Brain. 2020. PMID: 33103734 No abstract available.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2020 Apr 1;143(4):1045. doi: 10.1093/brain/awaa082. Brain. 2020. PMID: 32318734 No abstract available.
Optogenetic and chemogenetic therapies for epilepsy.
Walker MC, Kullmann DM. Walker MC, et al. Among authors: kullmann dm. Neuropharmacology. 2020 May 15;168:107751. doi: 10.1016/j.neuropharm.2019.107751. Epub 2019 Sep 5. Neuropharmacology. 2020. PMID: 31494141 Review.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2020 Dec 5;143(11):3169. doi: 10.1093/brain/awaa378. Brain. 2020. PMID: 33278821 No abstract available.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2020 May 1;143(5):1285. doi: 10.1093/brain/awaa118. Brain. 2020. PMID: 32438413 No abstract available.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2020 Mar 1;143(3):715. doi: 10.1093/brain/awaa040. Brain. 2020. PMID: 32203576 No abstract available.
Editorial.
Kullmann DM. Kullmann DM. Brain. 2020 Sep 1;143(9):2625. doi: 10.1093/brain/awaa280. Brain. 2020. PMID: 32947618 No abstract available.
290 results